Skip to content

Study on potential categories and influencing factors of frailty in lung cancer patients treated with radiotherapy

Study on potential categories and influencing factors of frailty in lung cancer patients treated with radiotherapy

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081213
Enrollment
Unknown
Registered
2024-02-26
Start date
2023-05-01
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumor radiation therapy nursing

Interventions

Observation group:Convenience sampling method was used to select lung cancer radiotherapy patients who were hospitalized in the Department of Radiation Therapy, the Third Affiliated Hospital of Kunmin

Sponsors

Yunnan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: ? Age > 18 years old, normal communication, no cognitive impairment; ? Patients with pathological or cytological diagnosis of lung cancer; ? Informed consent, able to cooperate in answering questions and voluntary participation; ? Clear consciousness, able to understand the scale content.

Exclusion criteria

Exclusion criteria: ? Patients with other serious physical or mental diseases or with serious complications; ? Patients with language expression and communication disorders; Patients who are receiving other drugs that can cause neurological toxicity; ? serious heart, liver, kidney failure and bone marrow hematopoietic insufficiency.

Design outcomes

Primary

MeasureTime frame
General information questionnaire;Fried Frailty Phenotype;M D Anderson symptom inventory;Hospital anxiety and depression scale;Nutrition risk screening 2002;

Secondary

MeasureTime frame
Functional assessment of cancer therapy -general model;Social Support Bating Scale;

Countries

China

Contacts

Public ContactZhang jiang

Yunnan Cancer Hospital

1120209154@qq.com+86 135 2943 6130

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026